Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × OTHER × Lymphangioma × Clear all

Status

Completed 3 Recruiting 2 Unknown 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

Prostatic Neoplasms 8 Neuroblastoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Leukemia 4 Lambert-Eaton Myasthenic Syndrome 4 Carcinoma, Hepatocellular 4 Pheochromocytoma 3 Neuroendocrine Tumors 3 Lymphoma 3 Glioblastoma 3 Carcinoid Tumor 3 Sarcoma, Ewing 2 Sarcoma 2 Precancerous Conditions 2 Paraganglioma 2 Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Melanoma 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Glioma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

New Mexico Cancer Research Alliance

No longer available

Lymphangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡